Drug Profile
HIV vaccine - HIV-VAC
Alternative Names: NFU.Ac.HIVLatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Developer HIV-VAC
- Class AIDS vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV-1 infections
Most Recent Events
- 24 Jun 1999 Preclinical development for HIV-1 infections in Russia (Unknown route)